Search

everythinglearnresearchcommunity

for

Search:↓

Stress hormones like cortisol may trigger psoriasis flare-ups.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Applying 2% tofacitinib cream helped some children with severe hair loss grow back hair.

These skin conditions in African men need combined medical treatments and lifestyle changes.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The U.S. military's teledermatology program was effective in providing fast and successful skin care in remote locations, preventing unnecessary evacuations.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Hydroxychloroquine may help treat alopecia areata in children.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.